| Mg sulphate group (n=45) | Ozone group (n=45) | Control group (n=45) | P-value | |
---|---|---|---|---|---|
After 2 weeks | |||||
NRS | Improved ≥ 30% [n (%)] | 29 (64.4%) | 29 (64.4%) | 0 | <0.001* |
Improved < 30% [n (%)] | 16 (35.6%) | 16 (35.6%) | 45 (100%) | ||
ODI | Improved ≥ 15 [n (%)] | 35 (77.8%) | 29 (64.4%) | 0 | <0.001* |
Improved < 15 [n (%)] | 10 (22.2%) | 16 (35.6%) | 45 (100%) | ||
After 1 month | |||||
NRS | Improved ≥ 30% [n (%)] | 35 (77.8%) | 34 (75.6%) | 0 | <0.001* |
Improved < 30% [n (%)] | 10 (22.2%) | 11 (24.4%) | 45 (100%) | ||
ODI | Improved ≥ 15 [n (%)] | 41 (91.1%) | 41 (91.1%) | 0 | <0.001* |
Improved < 15 [n (%)] | 4 (8.9%) | 4 (8.9%) | 45 (100%) | ||
After 3 month | |||||
NRS | Improved ≥ 30% [n (%)] | 36 (80%) | 33 (73.3%) | 0 | <0.001* |
Improved < 30% [n (%)] | 9 (20%) | 12 (26.7%) | 45 (100%) | ||
ODI | Improved ≥ 15 [n (%)] | 45 (100%) | 44 (97.8%) | 1 (2.2%) | <0.001* |
Improved < 15 [n (%)] | 0 | 1 (2.2%) | 44 (97.8%) | ||
After 6 month | |||||
NRS | Improved ≥ 30% [n (%)] | 31 (68.9%) | 0 | 0 | <0.001* |
Improved < 30% [n (%)] | 14 (31.1%) | 45 (100%) | 45 (100%) | ||
ODI | Improved ≥ 15 [n (%)] | 43 (95.6%) | 0 | 0 | <0.001* |
Improved < 15 [n (%)] | 2 (4.4%) | 45 (100%) | 45 (100%) |